Torrent Pharmaceuticals manages to improve Unichem's FY19 profits

Losar comprised almost 20% of the acquired portfolio of Unichem

After an initial struggle, Torrent Pharmaceuticals has managed to improve the profitability of Unichem, which it acquired in December 2017, from 18 per cent to more than 30 per cent in 2018-19 (FY19). This is in line with the company’s domestic margins. Analysts point out that the profitiablity is the result of the company’s efforts towards rationalisation — of both manpower and tail-end or overlapping brands. 

Torrent has reduced its employee strength in FY19 by around 1,102 people, according to its annual report. It has a workforce of 13,598 employees as on March 31, vis-à-vis 14,700 as on March 2018. Of